Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis

Explore clinical trials studying Hidradenitis. Study availability and eligibility vary by location and protocol.

24 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis trial results

Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT06855498

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Investigative Site US106 Birmingham, Alabama, United States
  • Investigative Site US086 Birmingham, Alabama, United States
  • Investigative Site US098 Montgomery, Alabama, United States
  • Investigative Site US004 Phoenix, Arizona, United States
View all 318 locations
View Trial Details
Recruiting

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07213973

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
  • Saguaro Dermatology Phoenix, Arizona, United States
  • Uconn Health Farmington, Connecticut, United States
View all 30 locations
View Trial Details
Enrolling by Invitation

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07007637

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Birmingham, Alabama, United States
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Northridge, California, United States
View all 166 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411379

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Birmingham, Alabama, United States
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Fountain Valley, California, United States
  • Clinical Site Santa Monica, California, United States
View all 106 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411899

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Northridge, California, United States
  • Clinical Site Sacramento, California, United States
  • Clinical Site San Diego, California, United States
View all 109 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT05620823

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Investigative Site US303 Phoenix, Arizona, United States
  • Investigative Site US335 Arkansas City, Arkansas, United States
  • Investigative Site US307 Fort Smith, Arkansas, United States
  • Investigative Site US315 Laguna Niguel, California, United States
View all 104 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT05620836

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Investigative Site US240 Scottsdale, Arizona, United States
  • Investigative Site US237 Scottsdale, Arizona, United States
  • Investigative Site US214 Arkansas City, Arkansas, United States
  • Investigative Site US242 Fayetteville, Arkansas, United States
View all 101 locations
View Trial Details

Related conditions